Teligent
TLGT
#10570
Rank
โ‚ฌ14.17 M
Marketcap
0,15ย โ‚ฌ
Share price
-13.85%
Change (1 day)
1,648.29%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -โ‚ฌ36.78 Million

According to Teligent's latest financial reports the company's current earnings are โ‚ฌ46.29 Million. In 2020 the company made an earning of -โ‚ฌ33.81 Million a decrease over its 2019 earnings that were of -โ‚ฌ7.06 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-โ‚ฌ36.78 Million8.79%
2020-โ‚ฌ33.81 Million378.89%
2019-โ‚ฌ7.06 Million-46.87%
2018-โ‚ฌ13.29 Million10.47%
2017-โ‚ฌ12.03 Million-637.49%
2016โ‚ฌ2.23 M-179.64%
2015-โ‚ฌ2.81 Million-181.72%
2014โ‚ฌ3.43 M-4806.02%
2013-โ‚ฌ0.08 Million-97.35%
2012-โ‚ฌ2.77 Million6.23%
2011-โ‚ฌ2.6 Million-18.59%
2010-โ‚ฌ3.2 Million-11.37%
2009-โ‚ฌ3.61 Million98.4%
2008-โ‚ฌ1.82 Million156.15%
2007-โ‚ฌ0.71 Million-59.36%
2006-โ‚ฌ1.75 Million17.92%
2005-โ‚ฌ1.48 Million37.7%
2004-โ‚ฌ1.08 Million25.51%
2003-โ‚ฌ0.86 Million-289.84%
2002โ‚ฌ0.45 M-1605.88%
2001-โ‚ฌ0.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.15 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ15.99 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA